Showing results (191-200 of 220) with videos related to

Sort By:
Pageof 22
Cancer Chemotherapy Reports|November 1, 1975
Urinary excretion of polyamines by patients with advanced malignancyT P Waalkes, C W Gehrke, D C Tormey, et al.
Cancer Treatment Reports|September 1, 1978
Phase II study of adriamycin and bleomycin in patients with multiple myelomaJ M Bennett, R Silber, E Ezdinli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinomaD C Allred, G M Clark, A K Tandon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology GroupA Recht, R Gray, N E Davidson, et al.
Journal of the National Cancer Institute|August 15, 1990
Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancerR R Love, P A Newcomb, D A Wiebe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1983
A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancerD C Tormey, V E Weinberg, J F Holland, et al.
Cancer Treatment Reports|July 1, 1978
Phase II study of vinblastine, methyl-CCNU, and medroxyprogesterone in advanced renal cell cancerR G Hahn, N R Temkin, E D Savlov, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Prognostic potential of DNA flow cytometry measurements in node-negative breast cancer patients: preliminary analysis of an intergroup study (INT 0076)L G Dressler, L Eudey, R Gray, et al.
Pageof 22